Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors.
N Engl J Med
; 376(2): 125-135, 2017 01 12.
Article
in En
| MEDLINE
| ID: mdl-28076709
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Organometallic Compounds
/
Octreotide
/
Neuroendocrine Tumors
/
Gastrointestinal Neoplasms
/
Antineoplastic Agents
Type of study:
Clinical_trials
/
Guideline
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
N Engl J Med
Year:
2017
Type:
Article